Los Angeles Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $274K | Sell |
|
|||||
|
2025
Q1 | $1.32M | Sell |
|
|||||
|
2024
Q4 | $1.43M | Sell |
|
|||||
|
2024
Q3 | $2.2M | Buy |
|
|||||
|
2024
Q2 | $400K | Sell |
|
|||||
|
2024
Q1 | $736K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $990K | Buy |
|
|||||
|
2023
Q2 | $1.29M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $426K | Hold |
|
|||||
|
2022
Q2 | $467K | Sell |
|
|||||
|
2022
Q1 | $785K | Buy |
|
|||||
|
2021
Q4 | $575K | Sell |
|
|||||
|
2021
Q3 | $537K | Sell |
|
|||||
|
2021
Q2 | $608K | Sell |
|
|||||
|
2021
Q1 | $931K | Sell |
|
|||||
|
2020
Q4 | $1.44M | Buy |
|
|||||
|
2020
Q3 | $1.43M | Sell |
|
|||||
|
2020
Q2 | $2.35M | Buy |
|
|||||
|
2020
Q1 | $1.49M | Buy |
|
|||||
|
2019
Q4 | $210K | Sell |
|
|||||
|
2019
Q3 | $427K | Sell |
|
|||||
|
2019
Q2 | $894K | Sell |
|
|||||
|
2019
Q1 | $937K | Buy |
|
|||||
|
2018
Q4 | $540K | Buy |
|
|||||
|
2018
Q3 | $492K | Buy |
|
|||||
|
2018
Q2 | $312K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $217K | Buy |
|